Dr. Lal Pathlabs Ltd.

View in App
2330.65 +1.80 ▲0.1%

25 April 2024, 04:03:41 PM
Volume: 116,745

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.lalpathlabs.com
Market Cap 19,450.34 Cr.
Enterprise Value(EV) 18,788.94 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 39.52 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 58.96 Trailing Twelve Months Ending 2023-12
Industry PE 67.10 Trailing Twelve Months Ending 2023-12
Book Value / Share 222.14 Trailing Twelve Months Ending 2023-12
Price to Book Value 10.49 Calculated using Price: 2,330.00
Dividend Yield 0.52 Period Ending 2023-03
No. of Shares Subscribed 8.35 Cr. 83,477,852 Shares
FaceValue 10
About Dr. Lal Pathlabs Ltd.
The company is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.

Dr. Lal Pathlabs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Dr. Lal Pathlabs Ltd. Performance

View details >>
1 Day
+0.08%
1 Week
+0.14%
1 Month
+9.48%
3 Month
-3.87%
6 Month
-4.58%
1 Year
+21.62%
2 Year
-14.81%
5 Year
+117.87%
10 Year

Dr. Lal Pathlabs Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 37.14 32.45 28.45 25.32 23.76 23.74 26.89 26.45 15.8
Return on Capital Employed (%) 48.87 47.43 43.07 37.9 34.78 32.94 36.03 32.67 20.34
Return on Assets (%) 24.67 25.06 24.13 21.81 20.38 18.81 19.87 17.77 10.36

Dr. Lal Pathlabs Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 341 507 596 788 946 1,033 1,245 1,502 1,666 1,772
Non Curr. Liab. -5 12 -6 -9 -20 70 83 273 176 122
Curr. Liab. 112 91 85 116 138 227 274 500 470 471
Minority Int. 2 3 2 4 5 21 31 35 33 34
Equity & Liab. 450 613 676 899 1,069 1,351 1,633 2,310 2,345 2,399
Non Curr. Assets 168 189 210 276 255 459 488 1,435 1,372 1,320
Curr. Assets 282 424 467 623 814 893 1,145 875 973 1,079
Misc. Exp. not W/O
Total Assets 450 613 676 899 1,069 1,351 1,633 2,310 2,345 2,399

Dr. Lal Pathlabs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 660 791 912 1,057 1,203 1,330 1,581 2,087 2,017 2,172
Other Income 13 22 28 31 46 55 51 53 42 65
Total Income 673 813 940 1,088 1,249 1,385 1,633 2,140 2,059 2,237
Total Expenditure -504 -584 -675 -793 -910 -987 -1,145 -1,527 -1,527 -1,592
PBIDT 168 229 265 295 340 399 488 613 532 645
Interest 0 -1 -1 -1 -1 -15 -16 -30 -38 -32
Depreciation -28 -28 -28 -33 -38 -73 -77 -108 -150 -145
Taxation -43 -67 -81 -90 -100 -83 -98 -125 -103 -135
Exceptional Items
PAT 96 133 156 172 200 228 296 350 241 333
Minority Interest -1 -1 -1 -1 -1 -2 -5 -5 -2 -4
Share Associate
Other Related Items
Consolidated Net Profit 96 132 155 171 199 226 292 345 239 330
Adjusted EPS 17 16 19 20 24 27 35 41 29 40

Dr. Lal Pathlabs Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 98 122 159 171 197 219 284 398 447 456
Cash Fr. Inv. -90 -113 -163 -137 -172 -100 -26 -212 -449 -287
Cash Fr. Finan. -10 -1 0 -32 13 -55 -190 -139 136 -283
Net Change -2 8 -5 2 37 64 67 48 134 -114
Cash & Cash Eqvt 16 23 19 29 66 129 197 244 378 264

Dr. Lal Pathlabs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 55.23 55.05 55.05 55.05 55.03 55.01 54.61 54.60 54.60
Public 44.77 44.95 44.96 44.95 44.97 44.99 45.39 45.40 45.40
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Dr. Lal Pathlabs Ltd. Announcements

View details >>
Wed, 24 Apr 2024
Copy of Newspaper Publication
Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication
Tue, 09 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Dr. Lal Path Labs Ltd. has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Mon, 01 Apr 2024
Updates
Dr. Lal Path Labs Ltd. has informed the Exchange regarding 'Received Assessment Order issued by Income Tax Department'.

Dr. Lal Pathlabs Ltd. Technical Scans

View details >>
Thu, 25 Apr 2024
High Increase in 1 Month High Increase in 1 Month
High Increase in 5 Years High Increase in 5 Years
100 SMA Crossing 200 SMA From Above 100 SMA Crossing 200 SMA From Above
20 SMA Crossing 50 SMA From Below 20 SMA Crossing 50 SMA From Below
CCI Crossed Above 100 CCI Crossed Above 100

Dr. Lal Pathlabs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,520.15 +2.3%
Cipla Ltd. 113,471.29 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,218.75 +4.5%
Divi's Laboratories Ltd. 101,959.84 3,843.80 +0.8%
Zydus Lifesciences Ltd. 95,944.41 951.25 +1.9%
Mankind Pharma Ltd. 95,926.91 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,384.10 +1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.60 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,384.10 +1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.38 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,384.10 +1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,384.10 +1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,384.10 +1.6%

Dr. Lal Pathlabs Ltd. FAQ's

What is Dr. Lal Pathlabs share price?
Can I buy Dr. Lal Pathlabs shares now?
What is the Dividend Yield of Dr. Lal Pathlabs?
What is the Market Cap of Dr. Lal Pathlabs?
What are the key metrics to analyse Dr. Lal Pathlabs?
What is the 52 Week High and Low of Dr. Lal Pathlabs?
What is the trend of Dr. Lal Pathlabs share price?